|
ARF3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.510400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.035800E-01 |
| Normal-vs-Stage2 |
4.918300E-02 |
| Normal-vs-Stage3 |
7.457600E-01 |
| Normal-vs-Stage4 |
5.917600E-01 |
| Stage1-vs-Stage2 |
6.437900E-02 |
| Stage1-vs-Stage3 |
1.975560E-01 |
| Stage1-vs-Stage4 |
2.228800E-01 |
| Stage2-vs-Stage3 |
2.452300E-02 |
| Stage2-vs-Stage4 |
2.334100E-02 |
| Stage3-vs-Stage4 |
8.116200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.871800E-01 |
| Normal-vs-AfricanAmerican |
1.017580E-01 |
| Normal-vs-Asian |
6.103200E-01 |
| Caucasian-vs-AfricanAmerican |
1.538560E-01 |
| Caucasian-vs-Asian |
7.854600E-01 |
| AfricanAmerican-vs-Asian |
3.146600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.207000E-01 |
| Normal-vs-Female |
2.739400E-01 |
| Male-vs-Female |
1.267240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.807200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.262200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.381200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.125000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.427800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.315600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.935600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.964040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.670400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.207600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.569800E-02 |
| Classical-VS-Follicular |
7.667800E-01 |
| Classical-VS-Other |
1.052010E-01 |
| Classical-VS-Normal |
2.585800E-01 |
| Tall-VS-Follicular |
4.320300E-02 |
| Tall-VS-Other |
4.097800E-01 |
| Tall-VS-Normal |
2.608400E-01 |
| Follicular-VS-Other |
1.485200E-01 |
| Follicular-VS-Normal |
2.794200E-01 |
| Other-VS-Normal |
1.370950E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.771200E-01 |
| Normal-vs-N1 |
1.452770E-01 |
| N0-vs-N1 |
2.390000E-02 |
|
|
